Suppr超能文献

[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].

作者信息

Zöllner N, Keller C, Wolfram G

出版信息

Med Klin. 1976 Apr 30;71(18):768-74.

PMID:818496
Abstract

78 patients with hypercholesterolemia were treated with beta-pyridylcarbinol from 1964 to 1966. In 1972 42 patients could be contacted again, 37 of them were reexamined. 14 of these 42 patients were still taking beta-pyridylcarbinol in 1972. Those who had taken more than 0.9 gm per day had a lower serum cholesterol level than in the beginning of the treatment in 1964. Clinical signs of atherosclerosis (angina pectoris and peripheral arterial disease) were significantly less in this group of patients. Besides a few flush reactions or heartburn no side effects to treatment were noted. The two groups of patients, with whom the 14 were compared, included 9 who had been taking clofibrate since 1966 and 19 patients without drug treatment for hypercholesterolemia. Both groups had higher serum cholesterol levels than the group of 14 with beta-pyridylcarbinol treatment over 8 years.

摘要

相似文献

7
[Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
ZFA (Stuttgart). 1979 Jul 31;55(21):1199-205.
8
Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
Atherosclerosis. 1977 Aug;27(4):487-92. doi: 10.1016/0021-9150(77)90166-6.
10
A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
Am J Med Sci. 1979 May-Jun;277(3):255-61. doi: 10.1097/00000441-197905000-00002.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验